CA125 response to bevacizumab in recurrent ovarian cancer.

被引:1
|
作者
O'Cearbhaill, R. E. [1 ]
Zhou, Q. [1 ]
Iasonos, A. [1 ]
Diaz, J. P. [1 ]
Tew, W. P. [1 ]
Hensley, M. L. [1 ]
O'Flaherty, C. [1 ]
Aghajanian, C. [1 ]
Spriggs, D. R. [1 ]
Sabbatini, P. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.5077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5077
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [21] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Baron, AT
    Maihle, N
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 288 - 289
  • [22] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Andre T Baron
    Nita Maihle
    Nature Clinical Practice Oncology, 2005, 2 : 288 - 289
  • [23] Combined inhibin and CA125 assays in the detection of ovarian cancer
    Robertson, DM
    Cahir, N
    Burger, HG
    Mamers, P
    McCloud, PI
    Pettersson, K
    McGuckin, M
    CLINICAL CHEMISTRY, 1999, 45 (05) : 651 - 658
  • [24] Beyond CA125: the coming of age of ovarian cancer biomarkers
    Sasaroli, Dimitra
    Coukos, George
    Scholler, Nathalie
    BIOMARKERS IN MEDICINE, 2009, 3 (03) : 275 - 288
  • [25] Serum CA125 level before the development of ovarian cancer
    Kobayashi, H.
    Ooi, H.
    Yamada, Y.
    Sakata, M.
    Kawaguchi, R.
    Kanayama, S.
    Sumimoto, K.
    Terao, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 99 (02) : 95 - 99
  • [26] Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
    Weiland, Florian
    Martin, Karina
    Oehler, Martin K.
    Hoffmann, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (08) : 10568 - 10582
  • [27] Targeting CA125 transcription for ovarian cancer treatment.
    Yue, Er
    Yang, Guangchao
    Yao, Yuanfei
    Wang, Guangyu
    Zhang, Yanqiao
    Wang, Edward W.
    CANCER RESEARCH, 2021, 81 (13)
  • [28] Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer
    Zhang, Minghai
    Cheng, Shanshan
    Jin, Yue
    Zhao, Yaqian
    Wang, Yu
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1875 (02):
  • [29] SERUM CA125 LEVEL BEFORE THE DEVELOPMENT OF OVARIAN CANCER
    Kobayashi, H.
    Ooi, H.
    Yamada, Y.
    Sakata, M.
    Kawaguchi, R.
    Kanayama, S.
    Sumimoto, K.
    Terao, T.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2008, 30 (03): : 91 - 96
  • [30] Monitoring Ovarian Cancer: CA125 Trial Stirs Controversy
    Chitale, Radha
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (18) : 1233 - 1233